Sanofi
KRSA

Sanofi’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Sanofi’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.8M Buy
+1,994,011
New +$55.4M 10.13% 4

Other funds holding KRSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Sanofi's KRSA Position: Q3 2026 in Review

Sanofi opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2026: 1,994,011 shares worth $63.8M. The stake represents 10.13% of the portfolio and ranks #4 among its holdings.

5 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

  • Sanofi held 1,994,011 shares of Korsana Biosciences, Inc. Common Stock worth $63.8M as of Q3 2026.
  • Korsana Biosciences, Inc. Common Stock was a new Sanofi position in Q3 2026.
  • Korsana Biosciences, Inc. Common Stock made up 10.13% of Sanofi's portfolio in Q3 2026, its #4 holding.
  • 5 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2026.

Based on Sanofi's 13F filing for Q3 2026, filed 5 Nov 2026.